CVE-2024-35314
Mitel Micollab code injection
- Published21 Oct 2024
Description
A vulnerability in the Desktop Client of Mitel MiCollab through 9.7.1.110, and MiVoice Business Solution Virtual Instance (MiVB SVI) 1.0.0.25, could allow an unauthenticated attacker to conduct a command injection attack due to insufficient parameter sanitization. A successful exploit requires user interaction and could allow an attacker to execute arbitrary scripts.
CVSS 3.1 breakdown
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HAffected products
Remediation
No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.
References
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2024-35314 being actively exploited?
CVE-2024-35314 is not in the CISA KEV catalog. Its EPSS exploit probability is 1.80%.
How severe is CVE-2024-35314?
CVE-2024-35314 has a CVSS 3.1 base score of 9.8, rated critical. EPSS estimates a 1.80% probability of exploitation.
Which products are affected by CVE-2024-35314?
Affected products include Mitel Micollab, Mitel Mivoice Business Solution Virtual Instance.
How do I fix CVE-2024-35314?
Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2024-35314 against the real software inventory on every managed device, as each hourly inventory arrives. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.